MRNA upgraded to Neutral by BAML
Hammerstone MarketTalk reports that BAML upgraded MRNA to a Neutral rating, with no further details on target, catalyst, or timing provided in the feed.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.